First human test for potential new weight management drug begins
NCT ID NCT07232732
Summary
This early-stage study aims to check the safety and how the body processes a new drug called LY3549492 in healthy adults who are overweight or have obesity. About 120 participants will receive multiple doses over approximately 8 weeks while researchers monitor for side effects and measure drug levels in the blood. The main goal is to see if the drug is well-tolerated before testing it for effectiveness in future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fortrea Clinical Research Unit
RECRUITINGDaytona Beach, Florida, 32117, United States
Contact Phone: •••-•••-••••
Contact
-
Fortrea Clinical Research Unit
RECRUITINGDallas, Texas, 75247, United States
Contact Phone: •••-•••-••••
Contact
-
Fortrea Clinical Research Unit
COMPLETEDMadison, Wisconsin, 53704, United States
Conditions
Explore the condition pages connected to this study.